Preladenant
Overview
Preladenant is a pharmacological compound that acts as an adenosine receptor antagonist. It is primarily investigated for its potential use in the treatment of Parkinson's disease. Preladenant works by blocking the action of adenosine at the A2A receptor, which is thought to play a role in the modulation of dopaminergic activity in the brain.
Mechanism of Action
Preladenant is a selective antagonist of the adenosine A2A receptor. Adenosine is a neuromodulator that influences various physiological processes, including neurotransmission and cerebral blood flow. In the context of Parkinson's disease, adenosine A2A receptors are found in high concentrations in the striatum, a brain region involved in motor control. By blocking these receptors, preladenant may enhance dopaminergic signaling, thereby improving motor function in patients with Parkinson's disease.
Clinical Development
Preladenant has been the subject of several clinical trials to evaluate its efficacy and safety in the treatment of Parkinson's disease. These studies have explored its potential to improve motor symptoms and reduce "off" time in patients who are already receiving levodopa therapy. While some trials have shown promising results, others have not demonstrated significant benefits over existing treatments.
Pharmacokinetics
The pharmacokinetic profile of preladenant includes its absorption, distribution, metabolism, and excretion. Preladenant is administered orally and is absorbed into the bloodstream, where it reaches peak plasma concentrations within a few hours. It is metabolized primarily in the liver and excreted through the kidneys.
Side Effects
Common side effects of preladenant may include nausea, dizziness, and insomnia. As with any medication, the risk of side effects must be weighed against the potential benefits, and patients should be monitored for any adverse reactions during treatment.
Research and Future Directions
Research into preladenant and other adenosine receptor antagonists continues, as scientists seek to better understand their role in the treatment of Parkinson's disease and other neurological disorders. Future studies may focus on optimizing dosing regimens, identifying patient populations that may benefit most, and exploring combination therapies with other neuroprotective agents.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD